logo
logo
Sign in

Anti-GBM Disease market size in the 7MM is expected to rise by 2030 with a CAGR of 22.2% during the study period (2018–2030), Estimates DelveInsight

avatar
Ankit Nigam
Anti-GBM Disease market size in the 7MM is expected to rise by 2030 with a CAGR of 22.2% during the study period (2018–2030), Estimates DelveInsight

DelveInsight’s ‘Anti-GBM Disease Market Insights, Epidemiology, and Market Forecast 2030’ report delivers an in-depth understanding of the Anti-GBM disease, historical and forecasted epidemiology as well as the Anti-GBM Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

View Report: https://www.delveinsight.com/report-store/anti-glomerular-basement-membrane-anti-gbm-disease-market-insights

Some facts of Anti-GBM Disease Market are:

  • Delveinsight Estimates that the highest cases of Anti-GBM Disease in the 7MM were in United States, followed by the Germany, France, the United Kingdom, Italy, Spain, and Japan in 2020.
  • According to DelveInsight, In the United States, the total number of incident cases of Anti-GBM Disease was 532 cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
  • According to DelveInsight, In the year 2020, the total incident cases of Anti-GBM Disease were 522 cases in EU-5 which are expected to grow during the study period, i.e., 2018–2030.
  • According to DelveInsight, In Japan, the total number of incident cases of Anti-GBM Disease was 63 cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.


Anti-GBM Disease Pipeline Drugs and Companies:

·        Idefirix (Imlifidase/HMed-IdeS): Hansa Biopharma

·        And Others


View Report: https://www.delveinsight.com/report-store/anti-glomerular-basement-membrane-anti-gbm-disease-market-insights


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

·        Bacteremia Market

·        Central Retinal Vein Occlusion Market

·        Chondrosarcoma Market

·        Microsatellite Stable Colorectal Cancer Market

·        Progressive Multifocal Leukoencephalopathy Market

·        Prosthetic Joint Infection Market

·        Higher-Risk Chronic Myelomonocytic Leukemia Market

·        Upper Limb Hypertonia Market

·        X-linked Retinitis Pigmentosa Market

·        Keloid Market

·        Synchronous Endometrial And Ovarian Carcinoma Market

·        Autosomal Recessive Congenital Ichthyosis Market

·        Rituximab Biosimilars Insight

·        Adamantinoma Market

·        Hpv-induced Cancers Market

·        Pain Management Devices Market

·        Continuous Renal Replacement Therapy Machines Market

·        Parkinsons Disease Related Dementia Market

·        22q11.2 Deletion Syndrome Market

·        Pediatric Growth Hormone Deficiency Pghd Market

·        Brain Aneurysm Stents Market

·        Dermal Erythema Market

·        Pelvic Inflammatory Disease Market

·        Polypoidal Choroidal Vasculopathy Market


collect
0
avatar
Ankit Nigam
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more